XTAETHES
Market cap24mUSD
Dec 24, Last price
362.40ILS
1D
3.04%
1Q
-25.29%
Name
Thirdeye Systems Ltd
Chart & Performance
Profile
Thirdeye Systems Ltd. engages in the research and development of high-end object recognition algorithms within the thermal spectrum. It also develops solutions that are in service with the Israel Defense Forces and other defense companies. Its products include Chimera, a day-and-night system that incorporates an uncooled LWIR thermal imager and HD Day EO camera in a compact lightweight package; Meduza, an electro-optical scanning system that is used in drone recognition; Meduza-S, an optical radar to add the accuracy for anti-drone system; and Tesseract, a solution that upgrades payloads from passive operated observation devices to state-of-the-art drone detection payload by enabling it to detect, recognize, and track drones in the sky. The company's products also include GoIR, a flexible solution for outdoor extreme activities designed for difficult conditions and supplies thermal image quality; aEYE C2, a solution with state-of-the-art detection and classification AI algorithm; and aEYE, a solution that allows drones to perform fully functional patrolling tasks from takeoff to precise landing, using autonomous human detection capabilities and cloud-based AI with Chimera payload. It serves autonomous vehicles, maritime protection, critical assets, counter terrorism, border control, search and rescue, and airport security Industries in Israel and internationally. The company was formerly known as New Horizon Group Ltd. and changed its name to Thirdeye Systems Ltd. in May 2021. Thirdeye Systems Ltd. was incorporated in 1979 and is based in Netanya, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 14,820 42.20% | 10,422 31.54% | 7,923 33.95% | |||||||
Cost of revenue | 11,163 | 17,704 | 16,322 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 3,657 | (7,282) | (8,399) | |||||||
NOPBT Margin | 24.68% | |||||||||
Operating Taxes | 74 | 166 | ||||||||
Tax Rate | ||||||||||
NOPAT | 3,657 | (7,356) | (8,565) | |||||||
Net income | (501) -93.91% | (8,231) -79.38% | (39,927) 898.92% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 3,734 | 761 | 9,093 | |||||||
BB yield | -5.93% | -2.23% | -13.67% | |||||||
Debt | ||||||||||
Debt current | 3,355 | 2,874 | 1,316 | |||||||
Long-term debt | 5,330 | 6,673 | 3,343 | |||||||
Deferred revenue | 664 | 963 | ||||||||
Other long-term liabilities | 1,057 | 311 | 500 | |||||||
Net debt | 6,596 | 8,873 | 2,947 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (1,347) | (5,556) | (10,172) | |||||||
CAPEX | (27) | (120) | (158) | |||||||
Cash from investing activities | (27) | (76) | (158) | |||||||
Cash from financing activities | 2,721 | 4,557 | 11,513 | |||||||
FCF | 1,168 | (6,061) | (27,440) | |||||||
Balance | ||||||||||
Cash | 2,089 | 674 | 1,712 | |||||||
Long term investments | ||||||||||
Excess cash | 1,348 | 153 | 1,316 | |||||||
Stockholders' equity | (60,511) | (7,756) | (90) | |||||||
Invested Capital | 68,220 | 11,889 | 5,821 | |||||||
ROIC | 9.13% | |||||||||
ROCE | 47.44% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 19,424 | 17,835 | 15,414 | |||||||
Price | 3.24 69.75% | 1.91 -55.70% | 4.31 -35.52% | |||||||
Market cap | 63,012 84.88% | 34,083 -48.74% | 66,495 225.30% | |||||||
EV | 69,608 | 42,956 | 69,442 | |||||||
EBITDA | 4,161 | (6,797) | (8,006) | |||||||
EV/EBITDA | 16.73 | |||||||||
Interest | 1,065 | 890 | 1,004 | |||||||
Interest/NOPBT | 29.12% |